Skip to content
healthcare.dev

Livalo

NDC 66869-204, pitavastatin calcium, tablet, film coated, from Kowa Pharmaceuticals America, Inc..

Product NDC
66869-204
Status
Listed
Labeler
Kowa Pharmaceuticals America, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022363
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66869-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PITAVASTATIN CALCIUM2.09 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
66869-204-906686902049090 TABLET, FILM COATED in 1 BOTTLE, DISPENSING (66869-204-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/44dcbf97-99ec-427c-ba50-207e0069d6d2
  • NADAC price for package 66869020490

    GET /v1/drugs/nadac/66869020490

Use it

Look up 66869-204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66869-204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66869-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.